door Monique Buur | jul 19, 2023 | Geen categorie
FDA approval for nirsevimab to protect infants against RSV infections The US Food and Drug Administration (FDA) has approved Sanofi and AstraZeneca’s antibody nirsevimab for the prevention of respiratory syncytial virus (RSV) infections in newborns and infants born in...
door Monique Buur | jul 6, 2023 | Geen categorie
Het laatste nieuws! CbusineZ and Healty.Capital invest in Amsterdam UMC spin-off ikHerstel IkHerstel an app that helps patients recover after surgery, received a capital injection by CbusineZ – the investment arm of health insurer CZ – and investment company...
